CCL11 and breast cancer: In agreement with this the in vivo studies employing syngenic mice model of breast cancer revealed that administration of anti-Eotaxin or anti-Oncostatin M antibody resulted in significant reduction of tumor volume as compared to mock control or IgG injected mice.